Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,670 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Outstanding problems with response evaluation criteria in solid tumors (RECIST) in breast cancer.
Kimura M, Tominaga T. Kimura M, et al. Among authors: tominaga t. Breast Cancer. 2002;9(2):153-9. doi: 10.1007/BF02967580. Breast Cancer. 2002. PMID: 12016395
Combination chemotherapy with docetaxel and doxifluridine showed a beneficial outcome in advanced or recurrent breast cancer patients with longer disease-free interval.
Nishimura R, Tominaga T, Mitsuyama S, Aoyama H, Asaga T, Ohno S, Okuyama N, Kimura M, Iwase H, Kanda K, Koga T, Shiba E, Ikeda T. Nishimura R, et al. Among authors: tominaga t. Anticancer Res. 2004 May-Jun;24(3b):2085-91. Anticancer Res. 2004. PMID: 15274405 Clinical Trial.
[Evaluation of weekly paclitaxel and doxifluridine (5'-DFUR) combination therapy in patients with advanced or recurrent breast cancer].
Okamoto Y, Tominaga T, Okuyama N, Sawada T, Kou Y. Okamoto Y, et al. Among authors: tominaga t. Gan To Kagaku Ryoho. 2003 May;30(5):661-7. Gan To Kagaku Ryoho. 2003. PMID: 12795098 Japanese.
[CGS20267 (Letrozole), a new aromatase inhibitor: late phase II study for postmenopausal women with advanced or recurrent breast cancer (no. 1)--investigation of recommended clinical dose CGS20267 Study Group].
Abe R, Tominaga T, Nomizu T, Nomura Y, Takashima S, Koyama H, Sano M, Tohge T, Ueo H, Ikeda S, Ohashi Y; CGS20267 Study Group. Abe R, et al. Among authors: tominaga t. Gan To Kagaku Ryoho. 2002 May;29(5):729-40. Gan To Kagaku Ryoho. 2002. PMID: 12040677 Clinical Trial. Japanese.
[CGS20267 (Letrozole), a new aromatase inhibitor: late phase II study in postmenopausal women with advanced or recurrent breast cancer (no. 2)--evaluation of efficacy and safety at the recommended clinical dose CGS20267 Study Group].
Kimijima I, Tominaga T, Nomizu T, Nomura Y, Takashima S, Koyama H, Sano M, Tohge T, Ueo H, Ikeda S, Ohashi Y; CGS20267 Study Group. Kimijima I, et al. Among authors: tominaga t. Gan To Kagaku Ryoho. 2002 May;29(5):741-9. Gan To Kagaku Ryoho. 2002. PMID: 12040678 Clinical Trial. Japanese.
Phase III randomized trial of toremifene versus tamoxifen for Japanese postmenopausal patients with early breast cancer.
Kimura M, Tominaga T, Kimijima I, Takatsuka Y, Takashima S, Nomura Y, Kasumi F, Yamaguchi A, Masuda N, Noguchi S, Eshima N. Kimura M, et al. Among authors: tominaga t. Breast Cancer. 2014 May;21(3):275-83. doi: 10.1007/s12282-012-0394-6. Epub 2012 Sep 12. Breast Cancer. 2014. PMID: 22968626 Clinical Trial.
Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan.
Kimura M, Tominaga T, Takatsuka Y, Toi M, Abe R, Koyama H, Takashima S, Nomura Y, Miura S, Kimijima I, Tashiro H, Ohashi Y; Adjuvant CEF Research Group for Breast Cancer. Kimura M, et al. Among authors: tominaga t. Breast Cancer. 2010 Jul;17(3):190-8. doi: 10.1007/s12282-009-0132-x. Epub 2009 Jul 3. Breast Cancer. 2010. PMID: 19575284 Clinical Trial.
[Clinical trials of vnorelbine in breast cancer--its scientific usefulness and development history until regulatory approval].
Tominaga T. Tominaga T. Gan To Kagaku Ryoho. 2006 Apr;33(4):541-7. Gan To Kagaku Ryoho. 2006. PMID: 16612169 Review. Japanese.
Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery.
Tominaga T, Koyama H, Toge T, Miura S, Sugimachi K, Yamaguchi S, Hirata K, Monden Y, Nomura Y, Toi M, Kimijima I, Noguchi S, Sonoo H, Asaishi K, Ikeda T, Morimoto T, Ota J, Ohashi Y, Abe O. Tominaga T, et al. J Clin Oncol. 2003 Mar 15;21(6):991-8. doi: 10.1200/JCO.2003.06.014. J Clin Oncol. 2003. PMID: 12637462 Clinical Trial.
Metastasis of breast carcinoma to rectus abdominis muscle.
Kuroi K, Tominaga T. Kuroi K, et al. Among authors: tominaga t. Breast J. 2003 Jan-Feb;9(1):58-9. doi: 10.1046/j.1524-4741.2003.09112.x. Breast J. 2003. PMID: 12558677 No abstract available.
1,670 results
Jump to page
Feedback